Morgan Stanley (NYSE:MS) PT Raised to $101.00

Morgan Stanley (NYSE:MS) had its price objective raised by equities researchers at Oppenheimer from $97.00 to $101.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the financial services provider’s stock. Oppenheimer’s price target would indicate a potential upside of 11.94% from the company’s current price.

MS has been the subject of several other research reports. TheStreet upgraded shares of Morgan Stanley from a “c+” rating to a “b” rating in a research report on Wednesday, March 6th. Barclays upped their price target on shares of Morgan Stanley from $102.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, January 2nd. Royal Bank of Canada restated a “sector perform” rating and issued a $91.00 price target on shares of Morgan Stanley in a research report on Wednesday, March 27th. Evercore ISI upped their price target on shares of Morgan Stanley from $97.00 to $102.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Finally, Keefe, Bruyette & Woods upped their price objective on shares of Morgan Stanley from $94.00 to $98.00 and gave the company a “market perform” rating in a research note on Wednesday. Thirteen research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $97.79.

Morgan Stanley Stock Up 0.2 %

MS stock opened at $90.23 on Wednesday. Morgan Stanley has a 12 month low of $69.42 and a 12 month high of $95.57. The firm has a market cap of $146.77 billion, a PE ratio of 16.44, a P/E/G ratio of 1.80 and a beta of 1.43. The firm has a 50 day simple moving average of $88.82 and a 200 day simple moving average of $84.85. The company has a debt-to-equity ratio of 2.89, a current ratio of 0.75 and a quick ratio of 0.75.

Morgan Stanley (NYSE:MS) last issued its quarterly earnings results on Tuesday, April 16th. The financial services provider reported $2.02 EPS for the quarter, beating the consensus estimate of $1.69 by $0.33. The business had revenue of $15.14 billion during the quarter, compared to the consensus estimate of $14.42 billion. Morgan Stanley had a net margin of 9.57% and a return on equity of 10.87%. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.70 EPS. Equities research analysts forecast that Morgan Stanley will post 6.36 earnings per share for the current fiscal year.

Insider Buying and Selling at Morgan Stanley

In other news, insider Andrew M. Saperstein sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, January 30th. The shares were sold at an average price of $87.92, for a total transaction of $879,200.00. Following the completion of the transaction, the insider now directly owns 313,490 shares of the company’s stock, valued at approximately $27,562,040.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider Andrew M. Saperstein sold 26,655 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $87.19, for a total transaction of $2,324,049.45. Following the completion of the transaction, the insider now directly owns 286,835 shares of the company’s stock, valued at approximately $25,009,143.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Andrew M. Saperstein sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, January 30th. The stock was sold at an average price of $87.92, for a total transaction of $879,200.00. Following the transaction, the insider now directly owns 313,490 shares of the company’s stock, valued at $27,562,040.80. The disclosure for this sale can be found here. Insiders sold a total of 191,155 shares of company stock valued at $16,723,094 in the last ninety days. Company insiders own 0.24% of the company’s stock.

Institutional Investors Weigh In On Morgan Stanley

A number of hedge funds have recently made changes to their positions in MS. CGC Financial Services LLC increased its position in shares of Morgan Stanley by 5,200.0% during the 4th quarter. CGC Financial Services LLC now owns 265 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 260 shares in the last quarter. University of Texas Texas AM Investment Managment Co. acquired a new stake in shares of Morgan Stanley during the 4th quarter worth about $25,000. RVW Wealth LLC acquired a new stake in shares of Morgan Stanley during the 3rd quarter worth about $27,000. Glass Jacobson Investment Advisors llc increased its position in shares of Morgan Stanley by 77.3% during the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 328 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 143 shares in the last quarter. Finally, Janiczek Wealth Management LLC increased its position in shares of Morgan Stanley by 810.8% during the 3rd quarter. Janiczek Wealth Management LLC now owns 337 shares of the financial services provider’s stock worth $28,000 after purchasing an additional 300 shares in the last quarter. Institutional investors and hedge funds own 84.19% of the company’s stock.

Morgan Stanley Company Profile

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.